Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy

Fabrizio Starace, Adriana Ammassari, Maria Paola Trotta, Rita Murri, Patrizio De Longis, Crescenzo Izzo, Alfredo Scalzini, Antonella D'Arminio Monforte, Albert W Wu, Andrea Antinori

Research output: Contribution to journalArticle

Abstract

Affective disorders have been reported as the most common mental health problem in persons with HIV infection. Depression has a significant impact on the quality of life of persons living with HIV and AIDS and is associated with HIV disease progression and mortality, even after controlling for sociodemographic and clinical characteristics and substance abuse. Depression has been also reported as one of the main causes of poor adherence with antiretroviral regimens. However, no published investigation has specifically focused on the relationship between depression and adherence to antiretroviral therapy. Nonetheless, information on the association between depressive symptoms and adherence may be gathered from investigations carried out to explore determinants of adherence with antiretroviral therapy. Findings from available studies show a substantial and consistent relationship between adherence to antiretroviral regimens and depression. Early recognition and proper management of depressive comorbidity could be an effective intervention strategy to improve adherence and may make a difference in the quality of life, social functioning, and disease course of people with HIV.

Original languageEnglish (US)
JournalJournal of Acquired Immune Deficiency Syndromes
Volume31
Issue numberSUPPL. 3
StatePublished - Dec 15 2002

Fingerprint

Highly Active Antiretroviral Therapy
Depression
HIV
Quality of Life
Mood Disorders
HIV Infections
Substance-Related Disorders
Disease Progression
Comorbidity
Mental Health
Acquired Immunodeficiency Syndrome
Mortality
Therapeutics

Keywords

  • Adherence
  • Antiretroviral therapy
  • Depression
  • HAART
  • HIV treatment

ASJC Scopus subject areas

  • Virology
  • Immunology

Cite this

Starace, F., Ammassari, A., Trotta, M. P., Murri, R., De Longis, P., Izzo, C., ... Antinori, A. (2002). Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 31(SUPPL. 3).

Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. / Starace, Fabrizio; Ammassari, Adriana; Trotta, Maria Paola; Murri, Rita; De Longis, Patrizio; Izzo, Crescenzo; Scalzini, Alfredo; D'Arminio Monforte, Antonella; Wu, Albert W; Antinori, Andrea.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 31, No. SUPPL. 3, 15.12.2002.

Research output: Contribution to journalArticle

Starace, F, Ammassari, A, Trotta, MP, Murri, R, De Longis, P, Izzo, C, Scalzini, A, D'Arminio Monforte, A, Wu, AW & Antinori, A 2002, 'Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy', Journal of Acquired Immune Deficiency Syndromes, vol. 31, no. SUPPL. 3.
Starace F, Ammassari A, Trotta MP, Murri R, De Longis P, Izzo C et al. Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes. 2002 Dec 15;31(SUPPL. 3).
Starace, Fabrizio ; Ammassari, Adriana ; Trotta, Maria Paola ; Murri, Rita ; De Longis, Patrizio ; Izzo, Crescenzo ; Scalzini, Alfredo ; D'Arminio Monforte, Antonella ; Wu, Albert W ; Antinori, Andrea. / Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. In: Journal of Acquired Immune Deficiency Syndromes. 2002 ; Vol. 31, No. SUPPL. 3.
@article{ceec7e36659145c3b69f26878428f361,
title = "Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy",
abstract = "Affective disorders have been reported as the most common mental health problem in persons with HIV infection. Depression has a significant impact on the quality of life of persons living with HIV and AIDS and is associated with HIV disease progression and mortality, even after controlling for sociodemographic and clinical characteristics and substance abuse. Depression has been also reported as one of the main causes of poor adherence with antiretroviral regimens. However, no published investigation has specifically focused on the relationship between depression and adherence to antiretroviral therapy. Nonetheless, information on the association between depressive symptoms and adherence may be gathered from investigations carried out to explore determinants of adherence with antiretroviral therapy. Findings from available studies show a substantial and consistent relationship between adherence to antiretroviral regimens and depression. Early recognition and proper management of depressive comorbidity could be an effective intervention strategy to improve adherence and may make a difference in the quality of life, social functioning, and disease course of people with HIV.",
keywords = "Adherence, Antiretroviral therapy, Depression, HAART, HIV treatment",
author = "Fabrizio Starace and Adriana Ammassari and Trotta, {Maria Paola} and Rita Murri and {De Longis}, Patrizio and Crescenzo Izzo and Alfredo Scalzini and {D'Arminio Monforte}, Antonella and Wu, {Albert W} and Andrea Antinori",
year = "2002",
month = "12",
day = "15",
language = "English (US)",
volume = "31",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "SUPPL. 3",

}

TY - JOUR

T1 - Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy

AU - Starace, Fabrizio

AU - Ammassari, Adriana

AU - Trotta, Maria Paola

AU - Murri, Rita

AU - De Longis, Patrizio

AU - Izzo, Crescenzo

AU - Scalzini, Alfredo

AU - D'Arminio Monforte, Antonella

AU - Wu, Albert W

AU - Antinori, Andrea

PY - 2002/12/15

Y1 - 2002/12/15

N2 - Affective disorders have been reported as the most common mental health problem in persons with HIV infection. Depression has a significant impact on the quality of life of persons living with HIV and AIDS and is associated with HIV disease progression and mortality, even after controlling for sociodemographic and clinical characteristics and substance abuse. Depression has been also reported as one of the main causes of poor adherence with antiretroviral regimens. However, no published investigation has specifically focused on the relationship between depression and adherence to antiretroviral therapy. Nonetheless, information on the association between depressive symptoms and adherence may be gathered from investigations carried out to explore determinants of adherence with antiretroviral therapy. Findings from available studies show a substantial and consistent relationship between adherence to antiretroviral regimens and depression. Early recognition and proper management of depressive comorbidity could be an effective intervention strategy to improve adherence and may make a difference in the quality of life, social functioning, and disease course of people with HIV.

AB - Affective disorders have been reported as the most common mental health problem in persons with HIV infection. Depression has a significant impact on the quality of life of persons living with HIV and AIDS and is associated with HIV disease progression and mortality, even after controlling for sociodemographic and clinical characteristics and substance abuse. Depression has been also reported as one of the main causes of poor adherence with antiretroviral regimens. However, no published investigation has specifically focused on the relationship between depression and adherence to antiretroviral therapy. Nonetheless, information on the association between depressive symptoms and adherence may be gathered from investigations carried out to explore determinants of adherence with antiretroviral therapy. Findings from available studies show a substantial and consistent relationship between adherence to antiretroviral regimens and depression. Early recognition and proper management of depressive comorbidity could be an effective intervention strategy to improve adherence and may make a difference in the quality of life, social functioning, and disease course of people with HIV.

KW - Adherence

KW - Antiretroviral therapy

KW - Depression

KW - HAART

KW - HIV treatment

UR - http://www.scopus.com/inward/record.url?scp=0037114812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037114812&partnerID=8YFLogxK

M3 - Article

C2 - 12562037

AN - SCOPUS:0037114812

VL - 31

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - SUPPL. 3

ER -